| Line Item | 2021-12-31 | Y/Y |
|---|---|---|
| Revenue | $423K | -57.9% |
| Cost of Revenue | $268K | -50.9% |
| Gross Profit | $155K | -66.2% |
| R&D Expense | $134K | +35.6% |
| SG&A Expense | $2.0M | +81.4% |
| Operating Income | -$1.9M | -169.0% |
| Interest Expense | $2.1M | +83.2% |
| Net Income | -$849K | +69.5% |
| Line Item | 2021-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $773K | +2018.0% |
| Accounts Receivable | $52K | — |
| Inventory | $72K | +9.8% |
| Current Assets | $930K | +566.6% |
| Total Assets | $1.1M | +264.1% |
| Current Liabilities | $9.2M | -26.2% |
| Total Liabilities | $9.5M | -25.8% |
| Line Item | 2021-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$1.3M | -130.7% |
| Investing Cash Flow | -$30K | -18.6% |
| Financing Cash Flow | $2.1M | +234.0% |
| Stockholders' Equity |
| -$6.9M |
| +44.5% |